These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 39352924)

  • 1. Quantitative modeling of signaling in aggressive B cell lymphoma unveils conserved core network.
    Klinger B; Rausch I; Sieber A; Kutz H; Kruse V; Kirchner M; Mertins P; Kieser A; Blüthgen N; Kube D
    PLoS Comput Biol; 2024 Oct; 20(10):e1012488. PubMed ID: 39352924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival.
    Corso J; Pan KT; Walter R; Doebele C; Mohr S; Bohnenberger H; Ströbel P; Lenz C; Slabicki M; Hüllein J; Comoglio F; Rieger MA; Zenz T; Wienands J; Engelke M; Serve H; Urlaub H; Oellerich T
    Proc Natl Acad Sci U S A; 2016 May; 113(20):5688-93. PubMed ID: 27155012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
    Blix ES; Irish JM; Husebekk A; Delabie J; Forfang L; Tierens AM; Myklebust JH; Kolstad A
    BMC Cancer; 2012 Oct; 12():478. PubMed ID: 23072591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling.
    Walter R; Pan KT; Doebele C; Comoglio F; Tomska K; Bohnenberger H; Young RM; Jacobs L; Keller U; Bönig H; Engelke M; Rosenwald A; Urlaub H; Staudt LM; Serve H; Zenz T; Oellerich T
    Blood; 2017 Feb; 129(5):598-608. PubMed ID: 28064214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism.
    Mayr F; Kruse V; Fuhrmann DC; Wolf S; Löber J; Alsouri S; Paglilla N; Lee K; Chapuy B; Brüne B; Zenz T; Häupl B; Oellerich T; Engelke M
    Haematologica; 2024 May; 109(5):1445-1459. PubMed ID: 37916396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor.
    Kondo E; Harashima A; Takabatake T; Takahashi H; Matsuo Y; Yoshino T; Orita K; Akagi T
    Eur J Immunol; 2003 Jan; 33(1):1-11. PubMed ID: 12594826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
    Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ
    Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of tyrosine phosphorylation during the CD40-mediated rescue of Ramos-BL B cells from BCR-triggered apoptosis.
    Hristov KK; Knox KA; Mitev VI
    Int J Mol Med; 2005 Nov; 16(5):937-41. PubMed ID: 16211267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
    Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
    Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
    Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
    BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
    Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
    Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas.
    Choi J; Ceribelli M; Phelan JD; Häupl B; Huang DW; Wright GW; Hsiao T; Morris V; Ciccarese F; Wang B; Corcoran S; Scheich S; Yu X; Xu W; Yang Y; Zhao H; Zhou J; Zhang G; Muppidi J; Inghirami GG; Oellerich T; Wilson WH; Thomas CJ; Staudt LM
    Cancer Cell; 2024 May; 42(5):833-849.e12. PubMed ID: 38701792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition.
    Varano G; Raffel S; Sormani M; Zanardi F; Lonardi S; Zasada C; Perucho L; Petrocelli V; Haake A; Lee AK; Bugatti M; Paul U; Van Anken E; Pasqualucci L; Rabadan R; Siebert R; Kempa S; Ponzoni M; Facchetti F; Rajewsky K; Casola S
    Nature; 2017 Jun; 546(7657):302-306. PubMed ID: 28562582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cells.
    Mimori K; Kiyokawa N; Taguchi T; Suzuki T; Sekino T; Nakajima H; Saito M; Katagiri YU; Isoyama K; Yamada K; Matsuo Y; Fujimoto J
    Leukemia; 2003 Jun; 17(6):1164-74. PubMed ID: 12764385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas.
    Horn H; Kalmbach S; Wagener R; Staiger AM; Hüttl K; Mottok A; Bens S; Traverse-Glehen A; Fontaine J; Siebert R; Rosenwald A; Ott G
    Am J Surg Pathol; 2021 Mar; 45(3):356-364. PubMed ID: 33136583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
    Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas.
    Swart JM; Bergeron DM; Chiles TC
    J Immunol; 2000 Mar; 164(5):2311-9. PubMed ID: 10679065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.
    Gobessi S; Laurenti L; Longo PG; Sica S; Leone G; Efremov DG
    Blood; 2007 Mar; 109(5):2032-9. PubMed ID: 17038529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas.
    Refaeli Y; Young RM; Turner BC; Duda J; Field KA; Bishop JM
    PLoS Biol; 2008 Jun; 6(6):e152. PubMed ID: 18578569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.